The Rise of Exosome Technologies: A Strategic Overview for Healthcare Stakeholders
The Exosome Diagnostics and Therapeutics Market The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, is forecasted to grow at a robust CAGR of 81.2%, reaching US$59 million in 2024 and an impressive US$6848 million by 2032.
However, the candidates for exosome-based therapeutics are expected to be launched in the market from 2029 onwards. Thus, exosome...
Exosome Diagnostics and Therapeutics Market Outlook 2032: Industry Size, Share, Trends, Strategies, and Growth Forecast
The Exosome Diagnostics and Therapeutics Market is projected to grow from USD 59 million in 2024 to USD 6,848 million by 2032 at a CAGR of 108.9%. The market is being primarily driven by the emerging potential of exosome-based liquid biopsy, which offers non-invasive options for disease diagnosis, prognosis, and treatment response monitoring across various health conditions....
Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032
The Exosome Diagnostics and Therapeutics Market is projected to grow from USD 59 million in 2024 to USD 6,848 million by 2032 at a CAGR of 108.9%. The market is being primarily driven by the emerging potential of exosome-based liquid biopsy, which offers non-invasive options for disease diagnosis, prognosis, and treatment response monitoring across various health conditions....